The Connect 360 GLP-1 Program addresses the rise in diabetes and GLP-1 spend, providing substantial savings for SmithRx employer groups, and improving access to GLP-1 therapy during the current FDA drug shortages.

‍
Agenda Highlights:

• Overview of the GLP-1 program: Start with a broad overview of increased demand and GLP-1 spend.

• Key Program Details: FDA shortage information, GLP-1 compounding products, better understanding of how this program improves access to GLP-1 therapy and overall member experience.

• Program Participation: Member engagement and group enrollment details.

‍

We'll end with a Q&A to give you an opportunity to address your specific questions.

‍

‍